← Back to Clinical Trials
Recruiting NCT06305429

NCT06305429 Encouraging Positive Parenting Habits

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06305429
Status Recruiting
Phase
Sponsor D'Or Institute for Research and Education
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2024-06-01
Primary Completion 2025-06

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 10 Years
Study Type INTERVENTIONAL
Interventions
HabitE (effective parenting habit) program (in Brazilian Portuguese)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2024-06-01 with a primary completion date of 2025-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates the feasibility and preliminary impacts of a new parenting program consisting of a series of educational videos, automatically delivered via a popular texting platform. The program content for the feasibility study is focused on teaching parents strategies to better manage one of the commonly reported challenges that children face, a transition to a non-preferred activity. Parents with young children experiencing behavior difficulties with daily transition routines are invited to participate in the study.

Eligibility Criteria

Inclusion Criteria: * Parents of children aged from 4 to 10 years old * Parents experiencing behavior difficulties with daily transition routines (parent-report). Exclusion Criteria: * Parents that do not have the children living with them at least 5 days per week every week; * While participating parents are informed that the program was developed for children demonstrating symptoms of ADHD, the low symptom number will not be used as an exclusion criteria.

Contact & Investigator

Central Contact

Camila Bernardes

✉ camila.bfaria@idor.org

📞 +5521966834545

Frequently Asked Questions

Who can join the NCT06305429 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 10 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06305429 currently recruiting?

Yes, NCT06305429 is actively recruiting participants. Contact the research team at camila.bfaria@idor.org for enrollment information.

Where is the NCT06305429 trial being conducted?

This trial is being conducted at Brazil, Brazil.

Who is sponsoring the NCT06305429 clinical trial?

NCT06305429 is sponsored by D'Or Institute for Research and Education. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology